Analyst Reco. Novavax, Inc.

Equities

NVAX

US6700024010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			After market 05:49:36 pm
16 ^USD	-11.92%		16.14	+0.84%

Jun. 07	COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says	RE
Jun. 06	S&P 500, Nasdaq dip on the eve of US payrolls data	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating	May. 23	MT
Novavax Stockholder Shah Capital Withdraws Campaign Against Reelection of Directors	May. 20	MT
Shah Capital withdraws campaign against three Novavax directors	May. 20	RE
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; AMC Entertainment, GameStop to Advance	May. 14	MT
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi	May. 10	MT
HEDGE FUND SHAH CAPITAL SAYS NOVAVAX-SANOFI DEAL IS "A STEP IN T…	May. 10	RE
HEDGE FUND SHAH CAPITAL - NOVAVAX-SANOFI DEAL CONCURS WITH SHAH…	May. 10	RE
Novavax's Shareholder Shah Capital Urges Vote Against Re-Election of Directors	May. 06	MT
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup	May. 06	RE
Shah Capital urges Novavax shareholders to vote against three directors	May. 06	RE
Novavax investor Shah Capital to vote against three directors	May. 06	RE
Novavax Shareholder Shah Capital Pushes to Add 2 Nominees to Company's Board	Apr. 15	MT
Hedge fund Shah Capital urges Novavax board shake-up, FT says	Apr. 15	RE
Hedge fund Shah Capital urges board shake-up at Novavax over struggling Covid vaccine, FT reports	Apr. 15	RE
HC Wainwright Cuts Price Target on Novavax to $19 From $35, Keeps Buy Rating	Mar. 01	MT
B. Riley Trims Novavax's PT to $11 From $12 After Reaching Settlement on Gavi Arbitration Dispute, Keeps Buy Rating	Feb. 23	MT
WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge	Jan. 12	RE
Novavax: green light for updated Covid vaccine in Sweden	Dec. 14	CF
Job losses delight investors	Dec. 06
B. Riley Lowers Novavax's Price Target to $12 From $15 After Near-Term COVID-19 Sales Estimate Revisions, Maintains Buy Rating	Nov. 10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 10, 2024 at 02:52 pm EDT